Denial Management Services
We believe denial management should be measured not by activity volume, but by financial performance improvement. Revix MD helps identify denial root causes, recover delayed revenue, and prevent repeat denials through structured workflows.
What Practices Lose to Preventable Denials
According to MGMA and HFMA benchmarks, average denial rates across U.S. healthcare range between 5%–10%, while top-performing organizations maintain rates below 2%. Even small increases in denials can disrupt cash flow, extend Days in A/R, and reduce net collections.
Denials are not random. They are operational signals tied to gaps in eligibility verification, authorization workflows, coding accuracy, documentation quality, and payer policy alignment.
Common Denial Codes We Manage
Modifier inconsistency
Missing or incorrect information
Medical necessity denial
Bundling or included service
Non-covered charges
Clinical vs. Technical Denials
A critical distinction in healthcare denial management. Most vendors treat these the same. Revix MD builds distinct workflows for each, which is why our appeal outcomes are consistently higher.
Technical Denials (CO-4, CO-16)
Caused by front-end errors such as missing authorization, incorrect modifiers, or invalid patient data. These are resolved through workflow correction and process improvement at the intake level.
Clinical Denials (CO-50)
Driven by medical necessity, level of care, or documentation gaps. These denials require physician-supported appeals, payer policy alignment, and documentation and coding review to support a stronger recovery strategy.
Denial Analysis, Recovery & Appeal Management
Appeal Management Services
Structured, payer-specific appeal narratives supported by clinical documentation, coding validation, and policy references. Average appeal overturn rate: up to 78% across high-value denial categories.
Timely Filing Denial Recovery
We track payer deadlines, monitor claim status, and use aging claim follow-up to identify at-risk claims before timely filing issues turn into preventable revenue loss.
Root Cause Prevention
We span front-end intake, authorization controls, charge capture workflows, coding precision, and documentation integrity — transforming denial management from reactive correction into proactive control.
Specialty-Specific Patterns
This level of visibility transforms denial management from reactive correction into proactive control across your entire practice.
Performance Benchmarks That Matter
Matrix
Industry Average
Revix MD Standard
Denial Rate
5% – 10%
< 5%
First-Pass Clean Claim Rate
90% – 95%
97.4%
Appeal Overturn Rate
50% – 65%
Up to 78%
Days in A/R Reduction
–
Up to 37%
Net Collection Rate
93% – 96%
Up to 97%
Timely Filing Compliance
Often inconsistent
> 99%
Transform Denials into Revenue Opportunity
Denied claims represent revenue already earned. When managed strategically, they become an opportunity to improve operations and stabilize cash flow.
FAQs
What is your appeal overturn rate for clinical denials?
Our overturn rate reaches up to 78% for high-value clinical denials, including medical necessity cases, depending on documentation quality and payer policy alignment.
How do you handle timely filing denials?
We track payer deadlines in real time, prioritize at-risk claims and escalate before filing windows close to prevent permanent revenue loss.
What is the difference between a CO-16 and CO-50 denial?
CO-16 indicates missing or incorrect information (technical issue), while CO-50 is a medical necessity denial requiring clinical documentation and physician-supported appeal.
How quickly do you respond to new denials?
Denials are identified and routed within 24-48 hours through structured workflows, ensuring rapid response and faster resolution cycles.
Do you handle RAC audit-triggered denials differently?
Yes. Audit-driven denials require compliance-focused appeals with detailed documentation and policy justification. Our team follows strict regulatory alignment to reduce risk and improve outcomes.